Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.

Homozygous inactivation of WT1, a Wilms' tumor gene located on chromosome 11 at p13, is believed to predispose to Wilms' tumor and therefore may be a common occurrence in this cancer. The expression of this gene in primary Wilms' tumors was examined by northern and quantitative RNA slot blot analysis and compared with clinical, histologic, and molecular features of each case. The characteristic 3.2 kb RNA was readily detected in most primary tumors although there was marked variation in the level of WT1-specific transcripts. No abnormal-sized RNA products were detected and expression of WT1 was not coordinated with that of several other oncofetal genes: N-myc, insulinlike growth factor 2 (IGF-2), and c-myc. The relative abundance of WT1-specific RNA did correlate with the histologic category of Wilms' tumor such that those tumors with heterologous differentiation have, in general, lower relative levels of WT1 transcripts than those tumors without heterologous differentiation. These results further establish the heterogeneity of Wilms' tumor with respect to the expression of tumor-associated oncofetal genes and suggest a relationship between WT1 expression and cellular differentiation.

[1]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[2]  D. Housman,et al.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.

[3]  S. Fleming,et al.  Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. , 1991, Oncogene.

[4]  M. Skolnick,et al.  Familial predisposition to Wilms tumor does not segregate with the WT1 gene. , 1991, Genomics.

[5]  D. Housman,et al.  Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. , 1991, Genomics.

[6]  D. Housman,et al.  Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. , 1991, American journal of human genetics.

[7]  A. Feinberg,et al.  Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. , 1990, Science.

[8]  A. Feinberg,et al.  Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. , 1990, Science.

[9]  J. Bard,et al.  The candidate Wilms' tumour gene is involved in genitourinary development , 1990, Nature.

[10]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[11]  D. Housman,et al.  Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene , 1990, Cell.

[12]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[13]  N. Kiviat,et al.  Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. , 1990, Pediatric pathology.

[14]  P. Schofield,et al.  Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. , 1989, Development.

[15]  K. Alitalo,et al.  The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain , 1989, The Journal of cell biology.

[16]  L. Strong,et al.  Lack of linkage of familial Wilms' tumour to chromosomal band 11 p13 , 1988, Nature.

[17]  W. Cavenee,et al.  Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11 , 1988, Nature.

[18]  M. Mott,et al.  Expression of the N-myc oncogene in Wilms' tumour and related tissues. , 1988, Oncogene.

[19]  H. Chan,et al.  Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms tumor. , 1988, Genomics.

[20]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[21]  J. Irminger,et al.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Alt,et al.  Enhanced expression of the N-myc gene in Wilms' tumors. , 1986, Cancer research.

[23]  J. Scott,et al.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues , 1985, Nature.

[24]  M. Eccles,et al.  Expression of insulin-like growth factor-II transcripts in Wilms' tumour , 1985, Nature.

[25]  A. Feinberg,et al.  Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours , 1984, Nature.

[26]  A. Reeve,et al.  Loss of a Harvey ras allele in sporadic Wilms' tumour , 1984, Nature.

[27]  S. Orkin,et al.  Development of homozygosity for chromosome 11p markers in Wilms' tumour , 1984, Nature.

[28]  G. Bell,et al.  Sequence of a cDNA clone encoding human preproinsulin-like growth factor II , 1984, Nature.

[29]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[30]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[31]  S. Patil,et al.  Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. , 1983, The Journal of pediatrics.

[32]  A. Knudson,et al.  Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.